Restless legs syndrome

Restless legs syndrome
Sleep pattern of a Restless Legs Syndrome patient (red) vs. a healthy sleep pattern (blue).
ICD-10	G25.8
ICD-9	333.94
OMIM	102300 608831
DiseasesDB	29476
eMedicine	neuro/509
MeSH	D012148

WikiDoc Resources for Restless legs syndrome
Articles
Most recent articles on Restless legs syndrome Most cited articles on Restless legs syndrome Review articles on Restless legs syndrome Articles on Restless legs syndrome in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Restless legs syndrome Images of Restless legs syndrome Photos of Restless legs syndrome Podcasts & MP3s on Restless legs syndrome Videos on Restless legs syndrome
Evidence Based Medicine
Cochrane Collaboration on Restless legs syndrome Bandolier on Restless legs syndrome TRIP on Restless legs syndrome
Clinical Trials
Ongoing Trials on Restless legs syndrome at Clinical Trials.gov Trial results on Restless legs syndrome Clinical Trials on Restless legs syndrome at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Restless legs syndrome NICE Guidance on Restless legs syndrome NHS PRODIGY Guidance FDA on Restless legs syndrome CDC on Restless legs syndrome
Books
Books on Restless legs syndrome
News
Restless legs syndrome in the news Be alerted to news on Restless legs syndrome News trends on Restless legs syndrome
Commentary
Blogs on Restless legs syndrome
Definitions
Definitions of Restless legs syndrome
Patient Resources / Community
Patient resources on Restless legs syndrome Discussion groups on Restless legs syndrome Patient Handouts on Restless legs syndrome Directions to Hospitals Treating Restless legs syndrome Risk calculators and risk factors for Restless legs syndrome
Healthcare Provider Resources
Symptoms of Restless legs syndrome Causes & Risk Factors for Restless legs syndrome Diagnostic studies for Restless legs syndrome Treatment of Restless legs syndrome
Continuing Medical Education (CME)
CME Programs on Restless legs syndrome
International
Restless legs syndrome en Espanol Restless legs syndrome en Francais
Business
Restless legs syndrome in the Marketplace Patents on Restless legs syndrome
Experimental / Informatics
List of terms related to Restless legs syndrome

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Restless legs syndrome (RLS, or Wittmaack-Ekbom's syndrome) is a condition that is characterised by an irresistible urge to move one's legs. It is poorly understood, often misdiagnosed, and believed to be a neurological disorder.

It is sometimes mistakenly called "Ekbom's syndrome," but that is an entirely different condition that shares part of the Wittmaack-Ekbom syndrome eponym: delusional parasitosis, as both syndromes were described by the same person, Karl-Axel Ekbom.

Many doctors express the view that the incidence of restless leg syndrome is exaggerated by manufacturers of drugs used to treat it. Other physicians consider it a real entity that has specific diagnostic criteria.

Many people tap their feet or shake their legs resulting from a nervous tic, consumption of stimulants, drug side-effects or other factors; this is usually innocuous, unnoticed, and does not interfere with daily life, quite distinct from Restless Leg Syndrome.

Incidence/Prevalence

Restless Leg Syndrome affects an estimated 2.7% of the general population in the U.S.A..

Often sufferers think they are the only ones to be afflicted by this peculiar condition and are relieved when they find out that many others also suffer from it. The severity and frequency of the disorder vary tremendously. Many people only experience symptoms when they try to sleep, while others experience symptoms during the day. It is common to have symptoms on long car rides or during any long period of inactivity (like watching television or a movie, attending a musical or theatrical performance, etc.) Approximately 80-90% of people with RLS also have PLMD, Periodic Limb Movement Disorder, which causes slow "jerks" or flexions of the affected body part. These occur during sleep (PLMS = Periodic Limb Movement while Sleeping) or while awake (PLMW - Periodic Limb Movement while Waking).

About 10 percent of adults in North America and Europe may experience RLS symptoms, according to the National Sleep Foundation, which reports that "lower prevalence has been found in India, Japan and Singapore," indicating that ethnic factors, including diet, may play a role in the prevalence of this syndrome.

History

In a 1945 publication titled 'Restless Legs', Karl-Axel Ekbom described the disease and presented eight cases used for his studies.

Earlier studies were done by Thomas Willis (1622-1675) and by Theodor Wittmaack. Another early description of the disease and its symptoms were made by George Miller Beard (1839-1883).

Types

RLS is either primary or secondary.

• Primary RLS is considered idiopathic, or with no known cause. Primary RLS usually begins before approximately 40 to 45 years of age, and can even occur as early as the first year of life. In primary RLS, the onset is often slow. The RLS may disappear for months, or even years. It is often progressive and gets worse as the person ages. RLS in children is often misdiagnosed as growing pains.

• Secondary RLS often has a sudden onset and may be daily from the very beginning. It often occurs after the age of 40, however it can occur earlier. It is most associated with specific medical conditions or the use of certain drugs. The most commonly associated medical condition is iron deficiency, which accounts for just over 20% of all cases of RLS. The conditions include: pregnancy, varicose vein or venous reflux, folate deficiency, sleep apnea, uremia, diabetes, thyroid problems, peripheral neuropathy, Parkinson's disease and certain auto-immune disorders such as Sjögren's syndrome, Celiac Disease, and rheumatoid arthritis. Treatment of the underlying condition, or cessation of use of the offending drug, often eliminates the RLS.

Causes

See potential causal relationship between acidosis and RLS above in "Explanation." Dehydration may also be a cause of an urge to move one's legs, as some sufferers often find that drinking a glass of water may stop the urges for a short while. Certain medications may worsen RLS in those who already have it, or cause it secondarily. These include: anti-nausea drugs, certain antihistamines (often in over-the-counter cold medications), drugs used to treat depression (both older tricyclics and newer SSRIs), antipsychotic drugs, and certain medications used to control seizures.

Hypoglycemia has also been found to worsen RLS symptoms. Opioid detoxification has also recently been associated with provocation of RLS-like symptoms during withdrawal. For those affected, a reduction or elimination in the consumption of simple and refined carbohydrates or starches (for example, sugar, white flour, white rice and white potatoes) or some hard fats, such as those found in beef or biscuits, is recommended.

Both primary and secondary RLS can be worsened by surgery of any kind, however back surgery or injury can be associated with causing RLS. RLS can worsen in pregnancy.

Genetics

40% of cases of RLS are familial and are inherited in an autosomal dominant fashion with variable penetrance.

No one knows the exact cause of RLS at present. Research and brain autopsies have implicated both dopaminergic system and iron insufficiency in the substantia nigra (study published in Neurology, 2003). Iron is an essential cofactor for the formation of L-dopa, the precursor of dopamine. An Icelandic study in 2005 confirmed the presence of an RLS susceptibility gene also found previously in a smaller French-Canadian population. Various studies suggest chromosome 12q may indicate susceptibility to RLS.

Explanation

Restless Leg Syndrome (RLS) (which is also sometimes referred to as Jimmy Legs) may be described as uncontrollable urges to move the limbs to stop uncomfortable or odd sensations in the body, most commonly in the legs, but can also be in the arms and torso. Moving the affected body part modulates the sensations, providing temporary relief.

The sensations – and the need to move – may return immediately after ceasing movement, or at a later time. RLS may start at any age, including early childhood, and is a progressive disease for a certain portion of those afflicted, although the symptoms have disappeared permanently in some sufferers.

As with many diseases with diffuse symptoms, there is controversy among physicians, if RLS is a distinct syndrome. The US National Institute of Neurological Diseases and Stroke publishes an information sheet characterizing the syndrome but acknowledging it is a difficult diagnosis. Some physicians doubt that RLS actually exists as a legitimate clinical entity, but believe it to be a kind of "catch-all" category, perhaps related to a general heightened sympathetic nervous system (SNS) response that could be caused by any number of physical or emotional factors. Other clinicians associate it with lumbosacral spinal subluxations and life stress. Another possible explanation of RLS is acidosis, though this claim needs to be explored further. RLS as a result of acidosis/insufficient oxygen being circulated to the legs (which reduces acid build up) would explain why symptoms worsen when the legs are at rest, and why moving them (increasing circulation) offers some relief. The fact that iron offers relief for many can be explained by its vital role in hemoglobin, which is responsible for oxygen dispersion to the tissues. The legs would be more prone to the restless condition since they are furthest from the heart and lungs. Additionally, one may see below that many of the "lifestyle changes and other non-medicinal approaches" are related in some way or form to circulation (e.g. heat, stretching, movement), acid build up (e.g. too much exercise, ketosis from high-fat diets), or the amount of oxygen being dispersed in the blood (e.g. deep breathing, iron levels). It should be noted that this potential causal relationship between RLS and acidosis is purely speculative the time being, as far as the contributing editor is aware. If this causal relationship holds true, then finding the cause of the acidosis would most likely lead to the best treatment.

Some experts believe RLS and periodic limb movement disorder are strongly associated with ADHD in some children. Both conditions are hereditary and dopamine is believed to be involved. Many types of medication for both conditions are affecting the dopamine levels in the brain [4]

Diagnosis

Symptoms

• "An urge to move, usually due to uncomfortable sensations that occur primarily in the legs."

The sensations are unusual and unlike other common sensations, and those with RLS have a hard time describing them. People use words such as: uncomfortable, antsy, electrical, creeping, painful, itching, pins and needles, pulling, creepy-crawly, ants inside the legs, and many others. The sensation and the urge can occur in any body part; the most cited location is legs, followed by arms. Some people have little or no sensation, yet still have a strong urge to move.

• "Motor restlessness, expressed as activity, that relieves the urge to move."

Movement will usually bring immediate relief, however, often only temporary and partial. Walking is most common; however, doing stretches, yoga, biking, or other physical activity may relieve the symptoms. Constant and fast up-and-down movement of the leg, coined "sewing machine legs" by at least one RLS sufferer, is often done to keep the sensations at bay without having to walk. Sometimes a specific type of movement will help a person more than another.

• "Worsening of symptoms by relaxation."

Any type of inactivity involving sitting or lying – reading a book, a plane ride, watching TV or a movie, taking a nap - can trigger the sensations and urge to move. This depends on several factors: the severity of the person’s RLS, the degree of restfulness, the duration of the inactivity, etc.

• "Variability over the course of the day-night cycle, with symptoms worse in the evening and early in the night."

While some only experience RLS at bedtime and others experience it throughout the day and night, most sufferers experience the worst symptoms in the evening and the least in the morning.

NIH criteria

In 2003, a National Institutes of Health (NIH) consensus panel modified their criteria to include the following:

• (1) an urge to move the limbs with or without sensations
• (2) worsening at rest
• (3) improvement with activity
• (4) worsening in the evening or night.

Differential Diagnosis

• Chronic insomnia
• Deep Vein Thrombosis
• Delayed Deep Sleep Disorder
• Hyperthyroidism
• Peripheral neuropathy
• Peripheral Vascular Disease
• Sleep disturbance due to medications
• Vertebral disc disease

Treatment

See potential causal relationship between acidosis and RLS above in "Explanation." An algorithm for treating Primary RLS ( RLS without any secondary medical condition including iron deficiency, varicose vein, thyroid, etc.) was created by leading RLS researchers at the Mayo Clinic and is endorsed by the Restless Legs Syndrome Foundation. This document provides guidance to both the treating physician and the patient, and includes both nonpharmacological and pharmacological treatments. Treatment of primary RLS should not be considered unless all the secondary medical conditions are ruled out. Drug therapy in RLS is not curative and is known to have significant side effects and needs to be considered with caution. The secondary form of RLS has the potential for cure if the precipitating medical condition (iron deficiency, venous reflux/varicose vein, thyroid, etc.) is managed effectively.

Iron supplements

All people with RLS should have their ferritin levels tested; ferritin levels should be at least 50 mcg for those with RLS. Oral iron supplements, taken under a doctor's care, can increase ferritin levels. For some people, increasing ferritin will eliminate or reduce RLS symptoms. A ferritin level of 50 mcg is not sufficient for some sufferers and increasing the level to 80 mcg may greatly reduce symptoms. However, at least 40% of people will not notice any improvement. Treatment with IV iron is being tested at the US Mayo Clinic and Johns Hopkins Hospital. It is dangerous to take iron supplements without first having ferritin levels tested, as many people with RLS do not have low ferritin and taking iron when it is not called for can cause iron overload disorder, potentially a very dangerous condition.

New results from the first ever double-blind clinical study, performed at Örebro University Hospital show that all 29 out of 60 patients that were treated with IV-infusion of up to a total of 1000 mg of iron (in the form of iron saccharose, Venofer), were markedly improved after 3 weeks. The effect lasted for 5-6 months. Those 31 receiving placebo had just a slight effect after 3 weeks that additionally disappeared rapidly.

The treatment was given even if iron deficiency was not shown according to ferritin levels. Worries of anaphylactic reactions did not come true. This is probably due to the form the IV iron was given. Anaphylaxis has been associated predominantly with dextran based infusions.

Lifestyle changes and other non-medicinal approaches

Treatment for RLS is based on how disruptive the symptoms are. All people should review their lifestyle and see what changes could be made to reduce or eliminate their RLS symptoms. These include: finding the right level of exercise (too much worsens it, too little may trigger it); eliminating caffeine, smoking, and alcohol; changing the diet to eliminate foods that trigger RLS (different for each person, but may include eliminating sugar, triglycerides, gluten, sugar substitutes (aspartame), following a low-fat diet, etc.); keeping good sleep hygiene; treating conditions that may cause secondary RLS; avoiding or stopping OTC or prescription drugs that trigger RLS; adding supplements such as potassium, magnesium, B-12, folate, vitamin E, and calcium. Some of these changes, such as diet (particularly aspartame) and adding supplements are based on anecdotal evidence from RLS sufferers as few studies have been done on these alternatives.

For those who experience RLS infrequently and do not need or want to try medication, in addition to lifestyle changes they can try:

• some form of exercise for several minutes such as walking, stretching, meditation, yoga, etc. at bedtime
• heat or cold, such as a hot or cold bath, a heating pad, a cold cloth, or a fan
• soaking one's feet in hot water just prior to going to sleep
• engrossing the mind in a game, the computer, or figuring something out
• wearing compression stockings, tight pantyhose, or wrapping the legs in elastic bandages
• placing a pillow between the knees or upper-legs while lying in bed
• eating porridge oats or almonds daily for their magnesium content
• hot green tea can relieve symptoms
• deep breathing for one or two minutes
• Massage and chiropractic spinal manipulation provide significant relief for some patients.

Medicinal approaches

For those whose RLS disrupts or prevents sleep or regular daily activities, medication is often required. Many Doctors currently use, and the Mayo Clinic Algorithm includes, medication from four categories:

• 1) Dopamine agonists such as ropinirole, pramipexole, carbidopa/levodopa or pergolide:

Agent	Timeline	Comments
ropinirole	Approved In 2005 by the Food and Drug Administration to treat moderate to severe Restless Legs Syndrome	The drug was first approved for Parkinson's disease in 1997.
pramipexole (Mirapex, Sifrol, Mirapexen in the EU)	In February 2006, the EU Scientific Committee issued a positive recommendation for approving for the treatment of RLS in the EU. US FDA approved Mirapex in 2006.	-
rotigotine	Currently in process for US FDA and EU approval for RLS	Delivered via a transdermal patch
pergolide	In March 2007 was withdrawn from the U.S. market	Withdrawn due to implication in valvular heart disease, that was shown in two independent studies.

There are some issues with the use of dopamine augmentation. Dopamine agonists may cause augmentation. This is a medical condition where the drug itself causes symptoms to increase in severity and/or occur earlier in the day. Dopamine agonists may also cause rebound, when symptoms increase as the drug wears off. Also, a recent study indicated that dopamine agonists used in restless leg patients can lead to an increase in compulsive gambling.

• 2) Opioids such as propoxyphene, oxycodone, or methadone, etc.
• 3) Benzodiazepines, which often assist in staying asleep and reducing awakenings from the movements
• 4) Anticonvulsants, which often help people who experience the RLS sensations as painful, such as gabapentin

In a study of 10 patients, it was reported that partial relief with taking a supplemental magnesium salt such as magnesium oxide or magnesium gluconate once or twice a day, and reducing the dose if diarrhea develops. Magnesium sulfate is the most active form; however, magnesium supplementation can cause complications for patients with renal problems.

Controversies

Recently, several major pharmaceutical companies are reported to be marketing drugs without an explicit approval for RLS, which are "off-label" applications for drugs approved for other diseases. The Restless Leg Foundation received 44% of its $1.4 million in funding from these pharmaceutical groups. This has called into question the neutrality of this group (significant conflict of interest issue) and the course of action which they recommend to RLS patients.

See also

• Actigraphy
• Parasomnia
• Disease mongering

External links

• Template:NINDS
• Center for RLS, education at Johns Hopkins
• Restless Leg Syndrome Treatment, Diagnosis, and Symptoms at iVillage
• Template:DMOZ

Template:Diseases of the nervous system Template:SIB

Template:WikiDoc Sources